Cryo-Cell International, Inc. (CCEL)

NYSEAMERICAN: CCEL · IEX Real-Time Price · USD
7.57
-0.43 (-5.37%)
Mar 28, 2024, 12:28 PM EDT - Market closed
-5.37%
Market Cap 66.29M
Revenue (ttm) 31.34M
Net Income (ttm) -9.52M
Shares Out 8.29M
EPS (ttm) -1.14
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 38,038
Open 7.99
Previous Close 8.00
Day's Range 7.32 - 8.15
52-Week Range 2.95 - 8.15
Beta 0.49
Analysts n/a
Price Target n/a
Earnings Date Apr 19, 2024

About CCEL

Cryo-Cell International, Inc. engages in the cellular processing and cryogenic cellular storage with a focus on the collection and preservation of umbilical cord blood stem cells for family use. It provides cord tissue service that stores a section of the umbilical cord tissue, a source of mesenchymal stem cells that are used in regenerative medicine to treat a range of conditions, including heart, and kidney disease, ALS, wound healing, auto-immune diseases, multiple sclerosis, Alzheimer's disease, Parkinson's diseases. The company manufacture... [Read more]

Sector Healthcare
IPO Date Jan 21, 1997
Employees 82
Stock Exchange NYSEAMERICAN
Ticker Symbol CCEL
Full Company Profile

Financial Performance

Financial Statements

News

Cryo-Cell Announces Plans to Explore Strategic Alternatives and Spin-off Celle Corp. to Maximize Shareholder Value

OLDSMAR, Fla.--(BUSINESS WIRE)--Cryo-Cell International, Inc. (NYSE American LLC: CCEL) (the “Company” or “Cryo-Cell”), the world's first private cord blood bank to separate and store stem cells in 19...

3 days ago - Business Wire

Cryo-Cell Reports Financial Results for Fiscal Year Ended November 30, 2023

OLDSMAR, Fla.--(BUSINESS WIRE)--Cryo-Cell International, Inc. (NYSE American LLC: CCEL) (the “Company”), the world's first private cord blood bank to separate and store stem cells in 1992, announced r...

4 weeks ago - Business Wire

Cord Blood Banking Leader Cryo-Cell Reports Fiscal Third Quarter 2023 Financial Results

OLDSMAR, Fla.--(BUSINESS WIRE)--Cryo-Cell International, Inc. (NYSE American LLC Symbol: CCEL) (the “Company”), the world's first private cord blood bank to separate and store stem cells in 1992, anno...

5 months ago - Business Wire

Cord Blood Banking Leader Cryo-Cell Reports Fiscal Second Quarter 2023 Financial Results

OLDSMAR, Fla.--(BUSINESS WIRE)--Cryo-Cell International, Inc. (NYSE American LLC: CCEL) (the “Company”), the world's first private cord blood bank to separate and store stem cells in 1992, announced r...

9 months ago - Business Wire

Cord Blood Banking Leader Cryo-Cell Reports Fiscal First Quarter 2023 Financial Results

OLDSMAR, Fla.--(BUSINESS WIRE)--Cryo-Cell International, Inc. (NYSE American LLC: CCEL) (the “Company”), the world's first private cord blood bank to separate and store stem cells in 1992, announced ...

1 year ago - Business Wire

Cryo-Cell Reports Financial Results for Fiscal Year Ended November 30, 2022

OLDSMAR, Fla., Feb. 28, 2023 (GLOBE NEWSWIRE) -- Cryo-Cell International, Inc. (NYSE American LLC: CCEL) (the “Company”), the world's first private cord blood bank to separate and store stem cells in ...

1 year ago - GlobeNewsWire

Cord Blood Banking Leader Cryo-Cell Reports Fiscal Third Quarter 2022 Financial Results

OLDSMAR, Fla., Oct. 14, 2022 (GLOBE NEWSWIRE) -- Cryo-Cell International, Inc. (NYSE American LLC Symbol: CCEL) (the “Company”), the world's first private cord blood bank to separate and store stem ce...

1 year ago - GlobeNewsWire

Cord Blood Banking Leader Cryo-Cell Announces Special Cash Dividend

OLDSMAR, Fla., Aug. 22, 2022 (GLOBE NEWSWIRE) -- Cryo-Cell International, Inc. (The Nasdaq Stock Market Symbol: CCEL) (“Cryo-Cell”), the world's first private cord blood bank to separate and store ste...

1 year ago - GlobeNewsWire

Cord Blood Banking Leader Cryo-Cell Announces Transfer to the NYSE American Stock Exchange

OLDSMAR, Fla., Aug. 17, 2022 (GLOBE NEWSWIRE) -- Cryo-Cell International, Inc. (The Nasdaq Stock Market Symbol: CCEL) (“Cryo-Cell”, the “Company”), the world's first private cord blood bank to separat...

1 year ago - GlobeNewsWire

Cord Blood Banking Leader Cryo-Cell Reports Fiscal Second Quarter 2022 Financial Results

OLDSMAR, Fla., July 11, 2022 (GLOBE NEWSWIRE) -- Cryo-Cell International, Inc. (The Nasdaq Stock Market Symbol: CCEL) (the “Company”), the world's first private cord blood bank to separate and store s...

1 year ago - GlobeNewsWire

Cord Blood Banking Leader Cryo-Cell Reports Fiscal First Quarter 2022 Financial Results

OLDSMAR, Fla., April 13, 2022 (GLOBE NEWSWIRE) -- Cryo-Cell International, Inc. (OTC:QB Markets Group Symbol: CCEL) (the “Company”), the world's first private cord blood bank to separate and store ste...

2 years ago - GlobeNewsWire

Cord Blood Banking Leader Cryo-Cell Announces Extravault Biorepository Service

OLDSMAR, Fla., March 16, 2022 (GLOBE NEWSWIRE) -- Cryo-Cell International, Inc. (The Nasdaq Stock Market Symbol: CCEL) (the “Company”), the world's first private cord blood bank to separate and store ...

2 years ago - GlobeNewsWire

Cryo-Cell Shares Its 2021 Annual Letter to Shareholders

OLDSMAR, Fla., March 09, 2022 (GLOBE NEWSWIRE) -- Cryo-Cell International, Inc. (The Nasdaq Stock Market Symbol: CCEL) (the “Company”), the world's first private cord blood bank to separate and store ...

2 years ago - GlobeNewsWire

Cryo-Cell Reports Financial Results for Fiscal Year Ended November 30, 2021

OLDSMAR, Fla., Feb. 22, 2022 (GLOBE NEWSWIRE) -- Cryo-Cell International, Inc. (The Nasdaq Stock Market Symbol: CCEL) (the “Company”), the world's first private cord blood bank to separate and store s...

2 years ago - GlobeNewsWire

Cord Blood Banking Leader Cryo-Cell Announces Its Intent to Advance Clinical Trials

OLDSMAR, Fla., Oct. 27, 2021 (GLOBE NEWSWIRE) -- Cryo-Cell International, Inc. (The Nasdaq Stock Market Symbol: CCEL) (the “Company”), the world's first private cord blood bank to separate and store s...

2 years ago - GlobeNewsWire

Cord Blood Banking Leader Cryo-Cell Reports Fiscal Third Quarter 2021 Financial Results

OLDSMAR, Fla., Oct. 15, 2021 (GLOBE NEWSWIRE) -- Cryo-Cell International, Inc. (The Nasdaq Stock Market Symbol: CCEL) (the “Company”), the world's first private cord blood bank to separate and store s...

2 years ago - GlobeNewsWire

Cryo-Cell International Announces Changes To Its Board of Directors

MIAMI, Sept. 20, 2021 (GLOBE NEWSWIRE) -- Cryo-Cell International, Inc. (Nasdaq:CCEL), the leader in cord blood and cord tissue cryopreservation services, announces the appointment of Mr. Mark Portnoy...

2 years ago - GlobeNewsWire

Cryo-Cell International Announces Uplisting to The Nasdaq Capital Market

Cryo-Cell International, Inc. (Symbol CCEL), The Leader In Cord Blood And Cord Tissue Cryopreservation Services, Today Announced That The Company's Common Stock Has Been Approved For Listing On The Na...

2 years ago - GlobeNewsWire

Cryo-Cell International Completes Acquisition of Real Estate Property for Its Institute for Cellular Therapies

Cryo-Cell International (symbol: CCEL) Purchases Real Estate Location for its Institute for Cellular Therapies in the Raleigh-Durham area.

2 years ago - GlobeNewsWire

Cryo-Cell International to Present at the Q3 Virtual Investor Summit on August 18, 2021

Oldsmar, Florida--(Newsfile Corp. - August 11, 2021) - Cryo-Cell International (OTC Pink: CCEL) today announced that David Portnoy, Chairman of the board and Co-CEO will be attending the Q3 Virtual In...

2 years ago - Newsfile Corp

Cryo-Cell International to Present at the Q3 Virtual Investor Summit

MIAMI, Aug. 11, 2021 (GLOBE NEWSWIRE) -- Cryo-Cell International announces that Chairman of the Board and Co-CEO, David Portnoy, will be presenting at the Q3 Virtual Investor Summit on August 18 th , ...

2 years ago - GlobeNewsWire

Cord Blood Banking Leader Cryo-Cell Reports Fiscal Second Quarter 2021 Financial Results

OLDSMAR, Fla., July 15, 2021 (GLOBE NEWSWIRE) -- Cryo-Cell International, Inc. (OTC:QB Markets Group Symbol: CCEL) (the “Company”), the world's first private cord blood bank to separate and store stem...

2 years ago - GlobeNewsWire

Cryo-Cell International Proudly Announces Two Ongoing COVID-19 Related Trials

MIAMI, May 10, 2021 (GLOBE NEWSWIRE) -- Cryo-Cell's Medical Director, Dr. Joanne Kurtzberg and her research team at The Marcus Center for Cellular Cures (MC3) at Duke University School of Medicine are...

3 years ago - GlobeNewsWire

Cord Blood Banking Leader Cryo-Cell Reports Fiscal First Quarter 2021 Financial Results

OLDSMAR, Fla., April 14, 2021 (GLOBE NEWSWIRE) -- Cryo-Cell International, Inc. (OTC:QB Markets Group Symbol: CCEL) (the “Company”), the world's first private cord blood bank to separate and store ste...

3 years ago - GlobeNewsWire